Syndax Pharmaceuticals (SNDX) PT Raised to $41 at JPMorgan
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $20.10 +4.20%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 17
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 17
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $41.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- BNP Paribas Exane Downgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Neutral
- Ultrapar Participacoes SA (UGPA3:BZ) (UGP) PT Raised to BRL39 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
